The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial.
 
Chiara Molinelli
Honoraria - Lilly
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Menarini
 
Virginia Delucchi
No Relationships to Disclose
 
Eva Blondeaux
Research Funding - Gilead Sciences
 
Luca Boni
Patents, Royalties, Other Intellectual Property - International Patent nr. PCT/EP2012/065661
 
Francesca Poggio
Honoraria - Lilly; Novartis
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences
 
Grazia Arpino
Consulting or Advisory Role - AstraZeneca Canada; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Novartis; Roche; Seagen; Viatris
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Roche; Seagen
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; Roche
 
Cecilia Nisticò
No Relationships to Disclose
 
Alessandra Fabi
No Relationships to Disclose
 
Michelino De Laurentiis
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Takeda
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences; Ipsen; Lilly; Menarini; Novartis; Roche; Sanofi; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Novartis; Pfizer; Roche; Sanofi
 
Fabio Puglisi
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca; Eisai; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Guilherme Nader Marta
Travel, Accommodations, Expenses - AstraZeneca
 
Alessandra Fozza
No Relationships to Disclose
 
Francesca Pitto
No Relationships to Disclose
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Lucia Del Mastro
Honoraria - Lilly; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Ipsen; Lilly; MSD; Novartis; Olema Oncology; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Olema Oncology; Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer; Roche